Building a healthy nation through research and innovation


Office of International Affairs


Terms and Conditions
to visit this site

 Local (non-MRC) and International Funding  

MRC researchers, before applying for external funding, please submit all proposals to the Project Office, for the attention of Pierre Boshoff.

The National Institutes of Health (NIH) - United States of America

The NIH is the primary federal agency, in the United States of America, for funding and performing medical research.

Please note the NIH Grants Policy Statement (10/98): If you are intending to apply for NIH funding, you might like to start by looking at their Grants Policy Statement which includes a description of their policy on awards to foreign institutions, international organizations, and domestic grants with substantial foreign components. See

  • NIH homepage
  • NIH funding opportunities and notices
    (Suggestion: scroll down to the 'Weekly Issue of the NIH Guide for Grants and Contracts' where you can read each week's list of new announcements, or subscribe to a listserv which will email them to you each week.) You need to check the eligibility requirements for these announcements, as not all are open to non-US applicants.

RSS feed of this information:

The Wellcome Trust United Kingdom

The Wellcome Trust is an independent charity funding research to improve human and animal health. Established in 1936 and with an endowment of around £13 billion, it is the UK's largest non-governmental source of funds for biomedical research.


European Commission, Framework Programme - (FP7) European Union

For guidelines on what is possible with the FP7, please visit the webpage of the European South Africa Science and Technology Advancement Programme (ESASTAP). South Africa and the European Union enjoy a privileged partnership marked by longstanding political, economic and development cooperation ties. The first intergovernmental agreement ever concluded between South Africa and the European Union, the Agreement on Science and Technology Cooperation signed in 1996, afforded South African researchers the opportunity to participate fully in the EU's Framework Programmes for Research and Technology Development. ESASTAP, a Specific Support Action, implemented by the South African Department of Science and Technology (DST) and funded by the European Commission (EC) under the Sixth Framework Programme (FP6), will significantly enhance the support and assistance available to both South African and European researchers to optimally leverage mutual benefits from this partnership. You will find information on searching for collaborating partners, mobility (SA to Europe and vice versa) funding, seed funding for building the early stages of collaborations, and how to access research funding.

European and Developing Countries Clinical Trials Partnership (EDCTP) European Union
The European & Developing Countries Clinical Trials Partnership (EDCTP) was created in 2003 as a European response to the global health crisis caused by the three main poverty-related diseases of HIV/AIDS, malaria and tuberculosis. These diseases account for over 6 million deaths each year, and the numbers are growing. Sub-Saharan Africa is the world's worst-affected region where besides ravaging lives, they impede development and cause poverty.

European Commission/FP-7: FP7 final calls for 2012.
EDCTP current calls


Special Programme for Research and Training in Tropical Diseases (TDR) World Health Organisation

TDR funds specific research projects in diseases of poverty, which cover infectious diseases and the culture and environment that contribute to these problems. It also supports the development of individuals and institutions in the countries where these diseases are prevalent.

TWAS international

TWAS is an autonomous international organization, based in Trieste, Italy, that promotes scientific excellence for sustainable development in the South. Originally named "Third World Academy of Sciences", it was founded in 1983 by a distinguished group of scientists from the South under the leadership of the late Nobel laureate Abdus Salam of Pakistan. The Academy's strength resides in the quality and diversity of its membership - internationally renowned scientists elected by their peers.

Bill & Melinda Gates Foundation private foundation

The Foundation funds research leading to innovations in health.

National Research Foundation (NRF) South Africa

The objective of the National Research Foundation (NRF) is to support and promote research in South Africa through funding, human resource development and the provision of the necessary research facilities, in order to facilitate the creation of knowledge, innovation and development in all fields of the natural and social sciences, humanities and technology.

South Africa the Good News

RSS feed by South Africa the Good News:

Comments and Submissions:
The content of this page is maintained by the MRC's Corporate Communications. If you have any comments or wish to have your funding opportunity, training opportunity, meeting (workshops, conferences, symposia, etc.) listed here, please contact The MRC reserves the right to decide what gets published.


ESASTAP additional support for SA researchers who participate in FP7 programmes
The Department of Science and Technology is committed to promoting and supporting South African participation in the European Union funding programmes and in bilateral collaborations with European researchers. As such, we have evaluated the instruments established to support SA-EU partnerships with the aim of improving our service to the broader South African research community. We have thus, in preparation for Horizon 2020 and South African participation in the remaining FP7 calls, made provision for FP7 co-investment funding to include cover for some of the research costs and researcher's time working on FP7 funded projects.

To find out more about funding support, visit the ESASTAP website's funding section

ESASTAP is a Specific Support Action implemented by the South African Department of Science and Technology and supported by the European Commission under the Seventh Framework Programme;, 012 843 6341 / 6338.

[Source: ESASTAP]

Image-guided Drug Delivery in Cancer (R01) (Funding Opportunity Announcement (FOA) Number PAR-13-185)
This Funding Opportunity Announcement (FOA) will support innovative research projects that are focused on image-guided drug delivery (IGDD), including real-time image guidance, monitoring, quantitative in vivo characterizations and validation of delivery and response. It will support research in development of integrated imaging-based platforms for multifunctional and multiplexed drug delivery systems in cancer and other diseases, quantitative imaging assays of drug delivery, and early intervention.

  • Earliest Submission Date: May 19, 2013
  • Letter of Intent Due Date(s): Not Applicable
  • Application Due Date(s): June 19, 2015; November 19, 2015, by 5:00 PM local time of applicant organization.
  • Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

The maximum period is 5 years.

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Purpose: This Funding Opportunity Announcement (FOA) will support innovative research in image-guided drug delivery (IGDD) for cancer and other diseases. The overarching goals of this FOA are to support the development of quantitative in vivo imaging methods for IGDD across different physical and physiological resolution scales in order to interrogate tumor-drug interaction, study biodistribution, pharmacokinetics, pharmacodynamics and therapeutic response. Studies that are directed towards translation of IGDD technology to patient care will be considered appropriate for this FOA. This FOA will support research in development of integrated imaging-based platforms for multifunctional and multiplexed drug delivery systems for therapy.

For further information, please see the full call for applications

[Source: NIH]

Detection of Pathogen-Induced Cancer (DPIC) (R01) (Funding Opportunity Announcement (FOA) Number PAR-13-190)
This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), is to encourage research projects which focus on the interactions of carcinogenic pathogens with the human microbiome and the host for the detection of pathogen-induced cancer (DPIC). This FOA encourages research to assess molecular signatures associated with risk and early detection of pathogen-induced cancer and chronic inflammation associated with progression to invasive cancer. 

  • Earliest Submission Date: June 10, 2013
  • Letter of Intent Due Date(s): 30 days before the application due date
  • Application Due Date(s): July 10, 2015; December 11, 2015, by 5:00 PM local time of applicant organization.

The maximum project period is 5 years.

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Background and Rationale: Microbial Pathogens and Carcinogenesis. More than 20% of cancers worldwide are known to be associated with microbial pathogens, including bacteria and viruses. Numerous epidemiological studies have reported an increased risk of precancerous lesions and cancers associated with pathogens. It is widely believed that perturbations in the composition of the human microbiota may increase the risk of, or cause, cancer.  This has led to the hypothesis that the microbial ecosystem and interactions between infectious pathogens and host cells play a critical role in modulating cancer-related pathways. Systemic factors, such as the microbiome, inflammatory status, and other microbial-related factors might also modulate progression of precancerous lesions to aggressive cancer.

For further information, please see the full call for applications

[Source: NIH]


NRF Support Desk regarding updating of CVs
The NRF is opening several calls for submitting applications for funding.  We therefore want to remind applicants to please update or complete their CVs on NRF Online as well.  This should be done whether the application gets submitted electronically on the NRF systems (NRF Interim or NRF Online) or in hard copy format (e-mailed as a PDF document).  Applications will unfortunately not be considered if the CV has not be completed or updated. Contact: Bettie de Beer, Support Desk Co-ordinator, GMSA:Support Desk, tel 012 481 4034, fax 086 623 2665,

[Source: NRF]

NRF re Acknowledgement of the National Research Foundation in research outputs accruing from NRF support
Please use “National Research Foundation (NRF) of South Africa” in these acknowledgements.

The ISI Web of Knowledge and specifically the Web of Science provide us with the ability to comprehensively analyse research publications. This capability allows the NRF to benchmark the performance of the NRF and the South African Science system as a whole. The funding agency analysis assists the NRF to measure its own performance in relation to other agencies. It also gives an indication of what is being funded by the various agencies both nationally and internationally.

As with every information system the quality and completeness of information generated are directly related to the quality and completeness of the data that are entered. While analysing the 2010 publications which involved South African authors we discovered that 55% of the 9 325 records did not contain sponsor information. A further analysis of the 55% revealed several authors who received grants from the NRF did not acknowledge the NRF. It is for this reason that we request all NRF Grantholders as well as the entire research community to acknowledge the NRF (if you receive NRF support) as well as other sponsors.  This is critically important as the information allows the NRF to present an evidence-based case to government for additional resources for research.  We trust that you will honour this request.

[Source: NRF]

Africa Portal
The Africa Portal ( is an online knowledge resource offering researchers and opinion leaders a forum to share their insights on Africa and publish their work on pressing areas of concern to policymakers and the public. It aims to fill the gap in accessibility to research and information on policy issues on the continent.

A key feature of the Africa Portal is the online library collection, holding over 2,500 books, journals and digital documents relating to African policy issues. The entire online repository is open access and available for free full-text download. A portion of the digital documents housed in the library have been digitised for the first time as an undertaking of the Africa Portal project.

The project is a collaborative undertaking between The South African Institute of International Affairs (SAIIA), the Centre for International Governance Innovation in Canada, and Makerere University in Uganda.

For further information on the Africa Portal, contact Shona Kohler,

[Source: NRF]

Contact the Webmaster
Last updated:
23 April, 2015
 Developed by Corporate Communications, South African Medical Research Council
   Intranet login